3,5-Dibromo-2-ethoxy-6-methylpyridine

Catalog No.: 
ACFAOK832
CAS No.: 
1822626-15-2
Molecular Formula: 
C8H9Br2NO
Molecular Weight: 
294.97
3,5-Dibromo-2-ethoxy-6-methylpyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$57.00In stockInquiry
1g95%$153.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,5-Dibromo-2-ethoxy-6-methylpyridine
IUPAC Name3,5-dibromo-2-ethoxy-6-methylpyridine
Molecular FormulaC8H9Br2NO
Molecular Weight294.97
SMILESCC1=C(Br)C=C(Br)C(OCC)=N1
InChI KeyWZCGVYODQJAHIU-UHFFFAOYSA-N
Synonym3,5-dibromo-2-ethoxy-6-methylpyridine;Pyridine, 3,5-dibromo-2-ethoxy-6-methyl-
CAS No.1822626-15-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACFAOK832 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMDOA942 route compound structure diagram
    ACMDOA942500587-45-1In Stock
  4. Then
  5. ACFAOK832 route product structure diagram
    ACFAOK8321822626-15-2In Stock
Inquiry

2. ACFAOK832 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFAOK832 route product structure diagram
    ACFAOK8321822626-15-2In Stock
Inquiry

3. ACFAOK832 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFAOK832 route product structure diagram
    ACFAOK8321822626-15-2In Stock
Inquiry

Comments (0)